A Fluorene Derivative, Induces Apoptosis and Ferroptosis to Overcome Sorafenib Resistance in Hepatocellular Carcinoma

被引：0
|
作者：
Tsai, Yiching [1 ]
Chiu, Chienchih [1 ]
Chang, Mengyang [2 ]
Chang, Wentsan [3 ]
机构：
[1] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2100
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [1] Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
    Jun Li
    Peng-Wen Wu
    Yuan Zhou
    Bo Dai
    Peng-Fei Zhang
    Yu-Hen Zhang
    Yang Liu
    Xiao-Lei Shi
    Cell Death & Disease, 9
  • [2] Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
    Li, Jun
    Wu, Peng-Wen
    Zhou, Yuan
    Dai, Bo
    Zhang, Peng-Fei
    Zhang, Yu-Hen
    Liu, Yang
    Shi, Xiao-Lei
    CELL DEATH & DISEASE, 2018, 9
  • [3] Sorafenib and Oleanolic Acid - a promising approach to overcome chemotherapy resistance in Hepatocellular Carcinoma (HCC)
    Lange, M.
    Abhari, B. Ahangarian
    Bechstein, W. O.
    Fulda, S.
    Liese, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 84 - 84
  • [4] STIM1 promotes acquired resistance to sorafenib by attenuating ferroptosis in hepatocellular carcinoma
    Ren, Ran
    Chen, Yu
    Zhou, Yu
    Shen, Luyao
    Chen, Yang
    Lei, Juan
    Wang, Jingchun
    Liu, Xudong
    Zhang, Nan
    Zhou, Dongqin
    Zhao, Huakan
    Li, Yongsheng
    GENES & DISEASES, 2024, 11 (06)
  • [5] Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma
    Hao, Shi-Hui
    Ma, Xiao-Da
    Xu, Li
    Xie, Jing-Dun
    Feng, Zi-Hao
    Chen, Jie-Wei
    Chen, Ri-Xin
    Wang, Feng-Wei
    Tang, Yu-Hao
    Xie, Dan
    Cai, Mu-Yan
    DRUG RESISTANCE UPDATES, 2024, 73
  • [6] From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma
    Wang, Zijian
    Zhou, Chunyang
    Zhang, Yiming
    Tian, Xinchen
    Wang, Haochen
    Wu, Jibiao
    Jiang, Shulong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [7] TNF-alpha is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
    Tan, Wenliang
    Luo, Xuan
    Li, Wenda
    Zhong, Jinyi
    Cao, Jun
    Zhu, Sicong
    Chen, Xianqing
    Zhou, Rui
    Shang, Changzhen
    Chen, Yajin
    EBIOMEDICINE, 2019, 40 : 446 - 456
  • [8] GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
    Zhou, Yu
    Zhao, Huakan
    Ren, Ran
    Zhou, Mingyue
    Zhang, Jiangang
    Wu, Zhijuan
    Chen, Yu
    Lei, Juan
    Chen, Yang
    Yu, Ying
    Li, Yongsheng
    THERANOSTICS, 2024, 14 (09): : 3470 - 3485
  • [9] Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
    Li, Zhong-jie
    Dai, Hui-qi
    Huang, Xiao-wei
    Feng, Ji
    Deng, Jing-huan
    Wang, Zi-xuan
    Yang, Xiao-mei
    Liu, Yu-jia
    Wu, Yong
    Chen, Pan-hong
    Shi, Huan
    Wang, Ji-gang
    Zhou, Jing
    Lu, Guo-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (02) : 301 - 310
  • [10] Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
    Zhong-jie Li
    Hui-qi Dai
    Xiao-wei Huang
    Ji Feng
    Jing-huan Deng
    Zi-xuan Wang
    Xiao-mei Yang
    Yu-jia Liu
    Yong Wu
    Pan-hong Chen
    Huan Shi
    Ji-gang Wang
    Jing Zhou
    Guo-dong Lu
    Acta Pharmacologica Sinica, 2021, 42 : 301 - 310
12345